Literature DB >> 20512481

[Zerebrale Amyloidangiopathie : Cerebral amyloid angiopathy].

F Block1.   

Abstract

Cerebral amyloid angiopathy (CAA) is defined by the accumulation of β-amyloid in the walls of cortical arteries. The risk factors of CAA include advanced age and the presence of certain alleles of apolipoprotein E. CAA mostly remains asymptomatic, but the classical manifestation is intracerebral hemorrhage. A definite diagnosis can only be made on the basis of histopathological examination. Detection of lobar hemorrhages and lobar microhemorrhages in imaging investigations support the diagnosis of CAA as long as other causes can be excluded.

Entities:  

Mesh:

Year:  2011        PMID: 20512481     DOI: 10.1007/s00115-010-3035-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.

Authors:  H C O'Donnell; J Rosand; K A Knudsen; K L Furie; A Z Segal; R I Chiu; D Ikeda; S M Greenberg
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

3.  Aspirin-associated intracerebral hemorrhage: clinical and radiologic features.

Authors:  K S Wong; V Mok; W W Lam; R Kay; A Tang; Y L Chan; J Woo
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

4.  Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy.

Authors:  M Hirohata; M Yoshita; C Ishida; S I Ikeda; A Tamaoka; S Kuzuhara; M Shoji; Y Ando; T Tokuda; M Yamada
Journal:  Eur J Neurol       Date:  2010-02-11       Impact factor: 6.089

5.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Authors:  D R Premkumar; D L Cohen; P Hedera; R P Friedland; R N Kalaria
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients.

Authors:  Jens Fiehler; Gregory W Albers; Jean-Martin Boulanger; Laurent Derex; Achim Gass; Niels Hjort; Jong S Kim; David S Liebeskind; Tobias Neumann-Haefelin; Salvador Pedraza; Joachim Rother; Peter Rothwell; Alex Rovira; Peter D Schellinger; Johannes Trenkler
Journal:  Stroke       Date:  2007-08-23       Impact factor: 7.914

Review 7.  Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage.

Authors:  Mark O McCarron; James A R Nicoll
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

8.  Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

9.  High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.

Authors:  M O McCarron; J A Nicoll
Journal:  Neurosci Lett       Date:  1998-05-08       Impact factor: 3.046

10.  Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study.

Authors:  C E Lovelock; A J Molyneux; P M Rothwell
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

View more
  2 in total

1.  [Cerebral amyloid angiopathy with associated vasculitis].

Authors:  S Preusse; S Vogelgesang; F Block
Journal:  Nervenarzt       Date:  2011-12       Impact factor: 1.214

Review 2.  Cerebral Amyloid Angiopathy in Stroke Medicine.

Authors:  Frank Block; Manuel Dafotakis
Journal:  Dtsch Arztebl Int       Date:  2017-01-20       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.